GlassScriptPhysician profile
Helen H Rogers
NPI 1609972611
$1,272.10
in general payments reported to CMS, 2019-2025
25 companies · $74.94 in 2025
The $74.94 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $165 · 2021: $391 · 2022: $234 · 2023: $106 · 2024: $114 · 2025: $74.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $295.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $323.70 | 2019-2021 | |
| Pfizer INC. | $259.47 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $113.28 | 2019-2025 | |
| Astellas Pharma US INC | $101.83 | 2019-2025 | Veozah |
| Mylan Pharmaceuticals INC. | $68.45 | 2020-2022 | |
| Baxter Healthcare | $60.97 | 2021-2024 | Perclot |
| Therapeuticsmd, INC. | $35.23 | 2020-2022 | |
| Axsome Therapeutics, INC. | $27.43 | 2024 | Auvelity |
| Hologic Sales and Service, LLC | $26.39 | 2019-2023 | Myosure Tissue Removal Device |
| Duchesnay USA Incorporated | $23.66 | 2019 | |
| Sage Therapeutics, LLC | $22.06 | 2023 | |
| Bausch Health US, LLC | $20.76 | 2023 | Wellbutrin, Aplenzin |
| Radius Health, INC. | $17.59 | 2020 | |
| Smith+Nephew, INC. | $16.21 | 2023 | Pico 14 |
| Shield Therapeutics INC | $15.70 | 2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $15.48 | 2025 | Myfembree |
| Teleflex LLC | $15.11 | 2022 | |
| Avion Pharmaceuticals | $15.07 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.66 | 2022 | |
| Exeltis, USA INC. | $14.34 | 2019 | |
| Organon LLC | $13.91 | 2022 | |
| Amag Pharmaceuticals, INC. | $13.69 | 2019 | |
| Evofem Biosciences, INC. | $13.17 | 2025 | Solosec, Phexx, Phexxi |
| Lupin INC. | $12.06 | 2020 | |
| Agile Therapeutics, INC. | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Helen Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.